Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Ivan Leo Pinto

Ivan Leo Pinto, Essex GB

Patent application numberDescriptionPublished
20100168122XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS - The present invention relates to compounds of formula (I) which are xanthine derivatives, processes for manufacture of said derivatives, pharmaceutical formulations containing these compounds and the use of the compounds in therapy, for example, in the treatment of diseases where under-activation of the HM74A receptor contributes to the disease or where activation of the receptor will be beneficial07-01-2010
20100179128XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS - The present invention relates to compounds of formula (I) which are xanthine derivatives, processes for the manufacture of said derivatives, pharmaceutical formulations containing these active compounds and the use of the compounds in therapy, for example, in the treatment of diseases where under-activation of the HM74A receptor contributes to the disease or where activation of the receptor will be beneficial07-15-2010

Ivan Leo Pinto, Stevenage GB

Patent application numberDescriptionPublished
20100010021NOVEL COMPOUNDS - The present invention relates to therapeutically active xanthine derivative compounds of Formula (I):01-14-2010
20100160354NOVEL COMPOUNDS - The present invention relates to therapeutically active xanthine derivative compounds of Formula (I):06-24-2010

Patent applications by Ivan Leo Pinto, Stevenage GB

Ivan Leo Pinto, Harlow GB

Patent application numberDescriptionPublished
20090118313Novel Compounds - Pyrimidone compounds of formula (I):05-07-2009
200901708775,6-Trimethylenepyrimidin-4-one compounds - Pyrimidone compounds of formula (I):07-02-2009
201001447655,6-TRIMETHYLENEPYRIMIDIN-4-ONE COMPOUNDS - Pyrimidone compounds of formula (I):06-10-2010

Patent applications by Ivan Leo Pinto, Harlow GB

Ivan Leo Pinto, Hertfordshire GB

Patent application numberDescriptionPublished
200802004682-Substituted 5-Membered Heteroaryl Carboxylates as Hm74a Receptor Agonists - Therapeutically active heteroaryl carboxylic acid derivatives of Formula (I) wherein R08-21-2008
20080214638Anthranilic Acid Derivatives Active as the Hm74a Receptor - Therapeutically active anthranilic acid derivatives of Formula (I) or of Formula (Ia) wherein R, R09-04-2008
20090209561Xanthine Derivatives with HM74A Receptor Activity - The present invention relates to therapeutically active xanthine compound derivatives, corresponding pharmaceutical formulations containing, processes for making or manufacture and the use of the aforementioned compounds in therapy, particularly in the treatment of diseases where under-activation of the HM74A receptor contributes to the disease or where activation of the receptor will be beneficial.08-20-2009

Patent applications by Ivan Leo Pinto, Hertfordshire GB

Ivan Leo Pinto, Hertfordshire DE

Patent application numberDescriptionPublished
20080221108Anthranilic Acid Derivatives As Hm74A Receptor Agonists - Therapeutically active anthranilic acid derivatives of Formula (I) wherein R09-11-2008